share_log

Psyched: FDA Warning, DEA's Telehealth Extension, CA Gov's Veto, Congress On Kratom, M&As & More

Psyched: FDA Warning, DEA's Telehealth Extension, CA Gov's Veto, Congress On Kratom, M&As & More

Psyched:美國食品藥品管理局的警告、美國藥物管理局的遠程醫療延期、加州州長的否決權、國會關於 Kratom、M&A 等
Benzinga ·  2023/10/17 03:57
Cybin And Small Pharma Shareholders Green Light Acquisition Resolution
Cybin和Small Pharma股東批准了收購決議
Clinical-stage psychedelics biotechs Canada-based Cybin Inc. (NYSE:CYBN) and UK-based Small Pharma Inc. (OTC:DMTTF) held their respective annual general and special shareholders meetings on October 12. They announced that voting results favored the arrangement plan for the latter's acquisition by the former.
臨床階段的迷幻藥生物技術公司總部位於加拿大的Cybin Inc.(紐約證券交易所代碼:CYBN)和總部位於英國的Small Pharma Inc.(場外交易代碼:DMTTF)於10月12日分別舉行了年度股東大會和特別股東大會。他們宣佈,投票結果贊成前者收購後者的安排計劃。
The TSX Venture Exchange conditionally approved the arrangement. Subject to the approval of BC's Supreme Court and other customary closing conditions, the arrangement's effective date would take place on or around October 23, 2023. Read more HERE.
多倫多證券交易所風險投資交易所有條件地批准了該安排。在不列顛哥倫比亞省最高法院批准和其他慣例成交條件的前提下,該安排的生效日期將在2023年10月23日左右生效。點擊此處閱讀更多。
FDA Issues Warning Over Ketamine Misuse, DEA Extends...
美國食品藥品管理...

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論